Clinical trial
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort - A Monocentric Study
NCT02502552 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort - A Monocentric Study
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- October 31, 2015
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease, inflammatory bowel disease, ulcerative colitis